Testosterone cypionate trials for Prostate cancer

All Testosterone cypionate trials · All Prostate cancer trials

Phase breakdown

Recruiting trials studying Testosterone cypionate for Prostate cancer

• Difluoromethylornithine and High Dose Testosterone With Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
  NCT06059118 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
  NCT04363164 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · 6 locations
• Sipuleucel-T Combined With Bipolar Androgen Therapy in Men With mCRPC
  NCT06100705 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
  NCT07142551 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
  NCT06039371 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• The COSMYC Trial (COmbined Suppression of MYC)
  NCT06922318 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many trials study Testosterone cypionate for Prostate cancer?

6 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.